Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy

Press/Media

Period	Jun 7 2024

Media coverage

Title	Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy
Media name/outlet	MOLECULAR CANCER
Country/Territory	United Kingdom
Date	06/7/24
URL	https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-024-02027-6
Persons	Y. Lynn Wang